# Adaptive MRI-Guided SBRT for Unresectable Primary or Oligometastatic Central Thorax and Abdominal Malignancies

> **NCT02264886** · PHASE1 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 30 (actual)

## Conditions studied

- Central Thorax Cancer
- Liver Cancer
- Non-Liver Abdominal Cancer

## Interventions

- **RADIATION:** MRI-guided stereotactive body radiation therapy

## Key facts

- **NCT ID:** NCT02264886
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2016-06
- **Final completion:** 2016-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2016-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02264886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02264886, "Adaptive MRI-Guided SBRT for Unresectable Primary or Oligometastatic Central Thorax and Abdominal Malignancies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02264886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*